APA (7th ed.) Citation

ET, D. R. N., AM, K., M, d. M. P., GA, F., CDL, M., LMH, d. M., . . . JR, P. (2020). Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases. Advances in rheumatology (London, England), 60(1), 32. https://doi.org/10.1186/s42358-020-00134-8

Chicago Style (17th ed.) Citation

ET, Dos Reis Neto, et al. "Revisiting Hydroxychloroquine and Chloroquine for Patients with Chronic Immunity-mediated Inflammatory Rheumatic Diseases." Advances in Rheumatology (London, England) 60, no. 1 (2020): 32. https://doi.org/10.1186/s42358-020-00134-8.

MLA (9th ed.) Citation

ET, Dos Reis Neto, et al. "Revisiting Hydroxychloroquine and Chloroquine for Patients with Chronic Immunity-mediated Inflammatory Rheumatic Diseases." Advances in Rheumatology (London, England), vol. 60, no. 1, 2020, p. 32, https://doi.org/10.1186/s42358-020-00134-8.